The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease

INTRODUCTION: Alzheimer's disease (AD) pathology, including the accumulation of amyloid beta (Aβ) species and tau pathology, begins decades before the onset of cognitive impairment. This long preclinical period provides an opportunity for clinical trials designed to prevent or delay the onset o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Alzheimers Dement (N Y)
Auteurs principaux: Lopez Lopez, Cristina, Tariot, Pierre N., Caputo, Angelika, Langbaum, Jessica B., Liu, Fonda, Riviere, Marie-Emmanuelle, Langlois, Carolyn, Rouzade-Dominguez, Marie-Laure, Zalesak, Martin, Hendrix, Suzanne, Thomas, Ronald G., Viglietta, Vissia, Lenz, Rob, Ryan, J. Michael, Graf, Ana, Reiman, Eric M.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2019
Sujets:
Perspective
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562315/
https://ncbi.nlm.nih.gov/pubmed/31211217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.02.005
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires